Interaction of St John's wort (Hypericum perforatum) with clozapine

被引:36
|
作者
Van Strater, Annelies C. P. [1 ]
Bogers, Jan P. A. M. [1 ,2 ,3 ]
机构
[1] Psychiat Ctr Rivierduinen, Dept Duin & Bollenstreek, NL-2215 ST Voorhout, Netherlands
[2] Psychiat Ctr Rivierduinen, Dept Haagstreek, NL-2215 ST Voorhout, Netherlands
[3] Psychiat Ctr Rivierduinen, Dept Midden Holland, NL-2215 ST Voorhout, Netherlands
关键词
clozapine; cytochrome P-450; herb-drug interactions; hypericum; P-glycoprotein; St John's wort; DRUG-DRUG INTERACTIONS; RENAL-TRANSPLANT PATIENTS; HERBAL INTERACTIONS; P-GLYCOPROTEIN; MECHANISMS; PHARMACOGENETICS; ANTIPSYCHOTICS; METABOLISM;
D O I
10.1097/YIC.0b013e32834e8afd
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
St John's wort (Hypericum perforatum) is notorious for its ability to induce the enzymes of the P450 system. Especially, it induces CYP1A2 and CYP3A4, enzymes that are closely involved in the metabolism of clozapine. We present a patient with schizophrenia, who was stable on a fixed dose with stable plasma level of clozapine, and who deteriorated after she started self-medicating with St John's wort. The reduced plasma clozapine level and the psychiatric condition normalized after the withdrawal of St John's wort. It is possible that, beside the induction of P450-enzymes, the induction of P-glycoprotein by St John's wort aggravated psychiatric deterioration of the patient. Physicians should be alert to patients self-medicating with over-the-counter medicines, especially when these medicines can lower clozapine concentrations below the therapeutic range. Int Clin Psychopharmacol 27:121-123 (C) 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:121 / 123
页数:3
相关论文
共 50 条
  • [1] Clinical risks of St John's Wort (Hypericum perforatum) co-administration
    Soleymani, Samaneh
    Bahramsoltani, Roodabeh
    Rahimi, Roja
    Abdollahi, Mohammad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (10) : 1047 - 1062
  • [2] Herb-Drug Interactions with St John's Wort (Hypericum perforatum): an Update on Clinical Observations
    Borrelli, Francesca
    Izzo, Angelo A.
    AAPS JOURNAL, 2009, 11 (04): : 710 - 727
  • [3] St John's wort (Hypericum perforatum)-induced psychosis: A case report
    Ferrara M.
    Mungai F.
    Starace F.
    Journal of Medical Case Reports, 11 (1)
  • [4] Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations
    Francesca Borrelli
    Angelo A. Izzo
    The AAPS Journal, 2009, 11 : 710 - 727
  • [5] Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content
    Chrubasik-Hausmann, Sigrun
    Vlachojannis, Julia
    McLachlan, Andrew J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (01) : 129 - 138
  • [6] The experimental and clinical pharmacology of St John's wort (Hypericum perforatum L.)
    Nathan, PJ
    MOLECULAR PSYCHIATRY, 1999, 4 (04) : 333 - 338
  • [7] Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans
    Scholz, Irene
    Liakoni, Evangelia
    Hammann, Felix
    Grafinger, Katharina Elisabeth
    Duthaler, Urs
    Nagler, Michael
    Kraehenbuhl, Stephan
    Haschke, Manuel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1466 - 1474
  • [8] The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)
    P J Nathan
    Molecular Psychiatry, 1999, 4 : 333 - 338
  • [9] Antinociceptive Properties of St. John's Wort (Hypericum perforatum) and Other Hypericum Species
    Stojanovic, Nikola M.
    Radulovic, Niko S.
    Randjelovic, Pavle J.
    Laketic, Darko
    NATURAL PRODUCT COMMUNICATIONS, 2016, 11 (11) : 1741 - 1747
  • [10] St John's wort (Hypericum perforatum):: drug interactions and clinical outcomes
    Henderson, L
    Yue, QY
    Bergquist, C
    Gerden, B
    Arlett, P
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 349 - 356